H19 and lung carcinoma: Additional lncRNAs whose expression has been shown to be deregulated in lung carcinoma include H19, which undergoes loss of imprinting and overexpression [85], MALAT-1 [15], cancer up-regulated drug resistant (CUDR) [86], and BC200 [87].